Tax Flash

With the enactment of the Affordable Care Act in 2010, several new tax provisions were to be implemented over the ensuing couple of years. One of these tax provisions is the Medical Device Excise Tax that went into effect on sales of taxable medical devices after December 31, 2012. This tax affects all taxpayers who are the manufacturers, producers, or importers of medical devices. Unlike sales tax, which is passed on to a taxpayer’s customers, this tax is imposed on the taxpayer/manufacturer/importer.

Many taxpayers may still be unaware that they are subject to the 2.3% excise tax on the sale of Medical Devices and failed to file the first Quarterly Federal Excise Tax Return (Form 720) on April 30, 2013. The next filing deadline for the 2nd Quarter is rapidly approaching and will be due on July 31, 2013.

A taxable medical device is defined as any device (as defined within the Federal Food, Drug, and Cosmetic Act) intended for humans. The term “device” is further defined as an instrument, apparatus, implement, machine, contrivance, implant, in vitro reagent, or other similar or related article, including any component, part, or accessory which is:

recognized in the official National Formulary, or the United States Pharmacopeia, or any supplement to them,

intended for use in the diagnosis of disease or other conditions, or in the cure, mitigation, treatment, or prevention of disease, in man or other animals, or

intended to affect the structure or any function of the body of man or other animals, and which does not achieve its primary intended purposes through chemical action within or on the body of man or other animals and which is not dependent upon being metabolized for the achievement of its primary intended purposes.

There has been much discussion about repealing various portions of the Affordable Care Act, and the Medical Device Excise Tax has been one of the more heavily debated areas regarding repeal. However, until the Medical Device Excise Tax is actually repealed (if even repealed), compliance is mandatory for those taxpayers who may be regarded as manufacturers, producers, or importers of medical devices.

If the tax liability exceeds $2,500 for the quarter, then semi-monthly deposits are required. Due to the complexity of the provisions of this Act, the IRS, within Notice 2012-77, has provided temporary penalty relief from the underpayment penalties for timely deposits for the first three quarters of 2013.

Marcum has a dedicated team of professionals with experience assisting taxpayers in the understanding of the Medical Device Excise Tax rules, as well as, experience in ensuring taxpayers are compliant with the filing requirements. If your company may be subject to the Medical Device Excise Tax or if you have any questions regarding the tax, please reach out to your Marcum tax professional.

Raffa - Marcum's Nonprofit & Social Sector Group's strength and competitive edge lies in the fact that we provide expertise and superior service across a variety of essential interrelated financial, technology and consulting competencies.

President Donald Trump pledged that his tax law would kill off breaks and complex loopholes for the wealthy. Instead, the overhaul has ushered in a new generation of maneuvers that taxpayers can exploit before Dec. 31 to minimize next year's bills.

The TCJA, signed into law in December 2017, provided sweeping changes affecting almost all businesses and individual taxpayers. One such change related to limitations on businesses deducting transportation fringe benefits related to employee transportation unless the employee recognizes income related to the fringe.

Marcum LLP is one of the largest independent public accounting and advisory services firms in the nation, with offices in major
business markets throughout the U.S., as well as Grand Cayman, China and Ireland.